About this source
- Kind
- Research
- Design
- Human observational
- Population
- 15 patients with 103 acquired melanocytic naevi
- Sample size
- 15
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Very small study with follow-up of about 12 months. It cannot show long-term risk.
Cited in
Moles (naevi) under dermoscopy
Afamelanotide · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.